It is my task to assess the place of implantation of radioactive isotopes into the pituitary for acromegaly, Cushing's syndrome, and diabetes mellitus, vis-a-vis neurosurgical treatment.
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When there is an extrasellar extension of a pituitary tumour, the treatment of choice is usually a neurosurgical approach supplemented by external radiation. This statement has to be qualified, however, for the extensions vary in their direction, their size, and in the symptoms which they cause. Eosinophilic tumours quite commonly give rise to these extensions as well as to acromegaly, although extrasellar extensions are not as frequent with them as with chromophobe tumours. On the other hand basophilic tumours associated with Cushing's syndrome do not extend outside the sellar cavity.
The extrasellar extensions of eosinophilic tumours may be quite large. The commonest direction is upwards, producing various patterns of visual failure from optic nerve, chiasmal, or tract compression. Other routes of extension are forwards and upwards between or into the frontal lobes, upwards and backwards invaginating andblocking the third ventricle, laterally into either the temporal lobe or the cavernous sinus, downwards into the sphenoidal sinus, and occasionally even through the superior orbital fissure into the orbit itself. These extensions all produce their own particular neurological pictures depending upon the structures involved. The direction and size of these extensions can usually be demonstrated by appropriate neuroradiological studies. A suprasellar extension, for instance, can generally be demonstrated better by air encephalography and by autotomography than by carotid arteriography. The usual neurosurgical approach for such suprasellar extensions is a transcranial subfrontal one with removal of as much as possible of the suprasellar extension, thus decompressing the optic nerve and chiasm, and later followed by external radiation. It is hard to see how these extensions can be adequately corrected by implantation of radioactive gold or yttrium seeds within the pituitary fossa or even by the transnasal surgical removal through the floor of the pituitary fossa, for any effect upon the extension which is causing symptoms would be merely indirect. Time does not permit discussion of details of neurosurgical techniques, but the mortality over a large series should not exceed 3 %, and the great majority of patients should recover vision sufficiently to resume their normal occupations.
The role of external radiation in the treatment of pituitary tumours is one concerning which there are some divergent views. Poppen (1963) and Davidoff & Feiring (1948) , for instance, have advocated primary supervoltage radiation therapy, but they are careful to point out that the visual fields should be charted frequently throughout the treatment. There is a real risk that a transient swelling of the gland may result from external radiation and precipitate a further decline in vision before a therapeutic shrinkage of the gland is obtained. Again, with high doses of supervoltage therapy cases of delayed radiation necrosis of the brain are still encountered. Radiation should, therefore, be employed as an adjunct to surgery for suprasellar extensions and not as a substitute.
In the past spontaneous remissions from the effects of these suprasellar extensions used to be seen occasionally. On the other hand catastrophic exacerbations due to pituitary hemorrhage or infarction may also occur. In general an extension is much more likely to increase gradually in size than to regress.
Destruction of the pituitary gland either completely or partially for some medical condition, such as the endocrine effects of pituitary tumours or diabetic retinitis, is a very different problem from the treatment of extensions of pituitary tumours. Deliberate destruction of the pituitary gland can be undertaken by several routes and techniques. I am more familiar with the surgical technique of transcranial hypophysectomy or of pituitary stalk section for disseminated carcinoma of the breast and diabetes mellitus. A year ago, before the Section of Laryngology, Mr Geoffrey Bateman and I discussed the relative merits of the transcranial approach and the new transnasal approaches, concluding that both were equally effective when the gland did not extend beyond the confines of the sella turcica (Bateman 1963 , Falconer 1963 . It seemed that the transcranial approach carried slight risks of damage to the optic nerves and olfactory nerves, while the transnasal approach carried risks of cerebrospinal rhinorrheea and of meningitis. However, patients after surgical hypophysectomy, whether transcranial or transnasal, subsequently require permanent hormonal replacement therapy with cortisone and thyroid, and they also lose their sexual functions. This has been my experience when I have performed surgical hypophysectomy on a few patients for acromegaly, for Cushing's syndrome, or for diabetes. The same need for replacement therapy, moreover, is also met with after pituitary function has been destroyed completely by radioactive implantations. However, Professor Russell Fraser and his colleagues claim that using appropriate precautions a partial destruction of the pituitary gland can be produced by pituitary implantation of 90Y and 198Au, and that in suitable cases the endocrine features of acromegaly and the retinal changes of diabetes mellitus can be mitigated without rendering the patients impotent or amenorrhoeic, or condemning them to a life-long dependence upon regular cortisone and thyroid substitution therapy (Joplin et al. 1961 ). If this is confirmed in a high proportion of cases, then this represents a distinct advance in therapy.
There are, however, risks inherent in the transnasal implantation of radioactive materials into the pituitary gland, and I have had a small experience of treating such complications in patients referred from other hospitals. In a large and well-controlled series such complications are infrequent, but none the less they are of interest, and from personal experience of cases seen by my colleague, Mr P H Schurr, and myself, I would divide them into three groups: (1) Hemorrhage into the pituitary gland. (2) Cerebrospinal rhinorrhoea and meningitis. (3) Delayed cranial nerve palsies, particularly of the optic nerve and the VI cranial nerve.
Heemorrhage into a pituitary tumour (or pituitary apoplexy) can occur spontaneously. I have encountered it twice after pituitary implantation. In one patient the mere insertion of the cannula into the gland set up a train of bleeding which led within a few days to blindness with severe headache. Fortunately she recovered her vision completely following an emergency frontal craniotomy with an intracapsular removal of a hmemorrhagic eosinophilic adenoma. In the second case the implantation produced within a few hours an almost complete bilateral ophthalmoplegia but without hemianopia, from which complete spontaneous recovery occurred.
In transcranial operations on patients with cerebrospinal rhinorrheea appearing some months after implantation, the sellar cavity is invariably largely empty but with fragments of tissue in its walls which show a few viable cells on histological examination. The cause of the cerebrospinal rhinorrhcea would appear to be fracturing of a thin sellar floor by the manipulations. The leakage of fluid is controlled by packing the sellar cavity with muscle. In two patients who developed optic nerve or chiasmal lesions nine months and seventeen months respectively after a second implantation into the sella, it was found that the optic chiasm had apparently been pulled by collagenous tissue into the empty sellar cavity. The visual failure was not relieved by dividing these adhesions. In my only case with a VI cranial nerve palsy which appeared a year after implantation I found an empty sellar cavity and no evidence of extension of the tumour (a basophil adenoma) in any direction. Possibly a delayed radiation necrosis was responsible for this lesion.
Thus the transnasal implantation of radioactive materials has its hazards, but as these appear to be infrequent, the method of treatment which the Hammersmith group are undertaking justifies a longer trial. It is a technique which requires careful checks and controls.
